Gordon DL - Search Results

1

Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures.

Adamson PJ, Al Kindi MA, Wang JJ, Colella AD, Chataway TK, Petrovsky N, Gordon TP, Gordon DL. Adamson PJ, et al. Among authors: gordon tp, gordon dl. Vaccine. 2017 Oct 9;35(42):5576-5580. doi: 10.1016/j.vaccine.2017.08.053. Epub 2017 Sep 6. Vaccine. 2017. PMID: 28888340

2

Serological responses following influenza A H1N1 2009 infection in adults.

Tan S, Gordon DL, Honda-Okubo Y, Petrovsky N, Phillips P, Huddleston S, Sadlon TA. Tan S, et al. Among authors: gordon dl. J Infect. 2011 May;62(5):388-93. doi: 10.1016/j.jinf.2011.03.002. Epub 2011 Mar 21. J Infect. 2011. PMID: 21420426

3

Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant.

Gordon DL, Sajkov D, Woodman RJ, Honda-Okubo Y, Cox MM, Heinzel S, Petrovsky N. Gordon DL, et al. Vaccine. 2012 Aug 3;30(36):5407-16. doi: 10.1016/j.vaccine.2012.06.009. Epub 2012 Jun 17. Vaccine. 2012. PMID: 22717330 Free PMC article. Clinical Trial.

4

Diversity in glycosaminoglycan binding amongst hMPV G protein lineages.

Adamson P, Thammawat S, Muchondo G, Sadlon T, Gordon D. Adamson P, et al. Viruses. 2012 Dec 14;4(12):3785-803. doi: 10.3390/v4123785. Viruses. 2012. PMID: 23242371 Free PMC article.

5

hMPV lineage nomenclature and heparin binding.

Adamson P, Thammawat S, Muchondo G, Sadlon T, Williams J, Gordon D. Adamson P, et al. Viruses. 2013 Oct 16;5(10):2546-7. doi: 10.3390/v5102546. Viruses. 2013. PMID: 24136041 Free PMC article.

6

Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.

Gordon D, Kelley P, Heinzel S, Cooper P, Petrovsky N. Gordon D, et al. Vaccine. 2014 Nov 12;32(48):6469-77. doi: 10.1016/j.vaccine.2014.09.034. Epub 2014 Sep 27. Vaccine. 2014. PMID: 25267153 Free PMC article. Clinical Trial.

7

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.

Gordon DL, Sajkov D, Honda-Okubo Y, Wilks SH, Aban M, Barr IG, Petrovsky N. Gordon DL, et al. Vaccine. 2016 Jul 19;34(33):3780-6. doi: 10.1016/j.vaccine.2016.05.071. Epub 2016 Jun 21. Vaccine. 2016. PMID: 27342914 Free PMC article. Clinical Trial.

8

Prevalence of macrolide-resistant Mycoplasma pneumoniae in South Australia.

Smith S, Adamson PJ, Sadlon TA, Gordon DL. Smith S, et al. Among authors: gordon dl. Pathology. 2016 Oct;48(6):639-42. doi: 10.1016/j.pathol.2016.06.004. Epub 2016 Sep 3. Pathology. 2016. PMID: 27596238 No abstract available.

9

Effect of sialidase fusion protein (DAS 181) on human metapneumovirus infection of Hep-2 cells.

Thammawat S, Sadlon TA, Adamson P, Gordon DL. Thammawat S, et al. Among authors: gordon dl. Antivir Chem Chemother. 2015 Dec;24(5-6):161-165. doi: 10.1177/2040206616665971. Epub 2016 Sep 20. Antivir Chem Chemother. 2015. PMID: 27620888 Free PMC article.

10

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine.

Honda-Okubo Y, Rajapaksha H, Sajkov D, Gordon D, Cox MMJ, Petrovsky N. Honda-Okubo Y, et al. Hum Vaccin Immunother. 2017 Jun 3;13(6):1-11. doi: 10.1080/21645515.2017.1279765. Epub 2017 Feb 14. Hum Vaccin Immunother. 2017. PMID: 28301280 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters